Role of Gnrh agonist in supporting pregnancy after frozen embryo transfer.
Phase 3
- Conditions
- Health Condition 1: N979- Female infertility, unspecified
- Registration Number
- CTRI/2023/09/057487
- Lead Sponsor
- Christian Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
More than or equal to 1 previous ART failure (frozen embryo transfers with a negative outcome)
Planned for hormone replacement cycle (HRC) or downregulated HRC frozen embryo transfer (FET)
Exclusion Criteria
Uterine anomalies (bicornuate/unicornuate uterus diagnosed by 2D/3D ultrasound)
Evidence of hydrosalpinx by ultrasound
Natural /modified stimulated cycles
Known drug allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical pregnancy rate per woman randomizedTimepoint: at the end of 6 weeks post recruitment
- Secondary Outcome Measures
Name Time Method Adverse drug reactions per woman randomizedTimepoint: up to 3 months post recruitment;Implantation rate per woman randomizedTimepoint: at 6 weeks post recruitment;Live birth rate per woman randomizedTimepoint: upto 10 months post recruitment;Miscarriage rate per clinical pregnancy <br/ ><br>Timepoint: up to 6 months post recruitment;Ongoing pregnancy rate per woman randomizedTimepoint: at 3 months post recruitment